Zicronapine

DB12188InvestigationalSmall molecule

Zicronapine has been used in trials studying the treatment of Schizophrenia.

Chemical structure of Zicronapine
Formula / weight
C22H27ClN2 · 354.92 g/mol (avg)

Resolves to

Compound
UNIIQZV11V7G6ACAS170381-16-5ChEMBLCHEMBL3039528PubChem11465618
Structure
InChIKeyBYPMJBXPNZMNQD-PZJWPPBQSA-NSMILESCN1CCN(CC1(C)C)[C@@H]1C[C@H](C2=C1C=C(Cl)C=C2)C1=CC=CC=C1
Targets
P28223HTR2AP21728DRD1P14416DRD2

What you can answer from here — as of January 29, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Zicronapine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In